Singapore: Baring Private Equity Asia announced recently that it has agreed to acquire Japanese drugmaker, Bushu pharmac...
Singapore: Bristol-Myers Squibb, a US-based pharma giant declared that it had inked a strategic accord with Japan's Ono ...
Singapore: Thermo Fisher Scientific's Ion PGM Dx next generation sequencing system has been listed with the US Food and ...
Singapore: Takeda Pharmaceutical has terminated the development program for orteronel (TAK-700) for prostate cancer foll...
Singapore: Agilent Technologies and Shimadzu are going to exchange RapidControl.NET (RC.Net) instrument drivers. Shimadz...
Singapore: Following footsteps of Microsoft, Samsung, Apple and other technology giants, Toshiba too has decided to incr...
Singapore: The Vietnamese Ministry of health recently inked a pact with Japan's medical universities in Kansai region an...
Singapore: Japan-based pharma major, Sosei, recently announced the acquisition of Jitsubo, a Japanese peptide technology...
US-based Taconic Biosciences, a leading provider of genetically modified solutions to researchers worldwide, announced a...
International Stem Cell Corporation, a California-based biotechnology company developing novel stem cell based therapies...
Singapore: Colorectal Cancer (CRC) therapeutics market in Asia-Pacific (APAC) is set to increase in value, from $1.9 bil...
Boston Therapeutics, Inc., a leading developer of complex carbohydrates to treat diabetes and inflammatory diseases, and...
Singapore: Global treatment market for Type 1 Diabetes (T1D) will expand from $6.6 billion in 2013 to an estimated $13.6...
Singapore: MMRGlobal received confirmation of the filings of a divisional application for its antibody technology in Jap...
Singapore: Italy-headquartered Health Robotics has signed two long-term contract extensions of its exclusive partnership...
Singapore: Japan's largest drug company Takeda Pharmaceutical has entered into a strategic investment partnership with U...
Shortage of skills and qualification among life science professionals to pursue risk laden activities is proving to be a...
Singapore: In a bid to provide a new treatment options to patients with multiple sclerosis in Japan, Israel's Teva Pharm...
